Hello everyone,

I am using retinoic acid to differentiate SH-SY5Y cells into neuronal cells to generate a Parkinson's disease model. I will perform MTT assay before using a neurotoxin of interest to generate a PD model again for another set of experiments but I am not sure if I have to differentiate the cells again because I have seen that the same cell line is used undifferentiated as well, for example in Alzheimer's disease research.

Is it a "must" for in vitro PD model?

Thank you

More İrem Akçalı's questions See All
Similar questions and discussions